BRINKLEY TRUEHEART: Open Payments
NPI 1669021101 · WINTER HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 19 payments from 13 companies in 2025. Trend: 2023 $194 · 2024 $111 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $72 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Eisai Inc. | 2 | $39 |
| Boston Scientific Corporation | 1 | $31 |
| Novo Nordisk Inc | 1 | $26 |
| Dexcom, Inc. | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Exact Sciences Corporation | 1 | $16 |
Products named: ELIQUIS, AIRSUPRA, REXULTI, Leqembi, BodyGuardian, PREVNAR 20, Ozempic, Dexcom G6 Transmitter.
Industry payments across FL — which companies pay providers there.
